How to stop a blood brain-barrier in India
Blood-brain barrier, also known as blood flow restriction or blood flow reduction, is a vital part of modern medicine.
It prevents blood from clogging the brain and leading to cognitive problems.
But a blood-brain-barricure barrier can be hard to come by in India.
And for a lot of Indians, it’s not just a matter of convenience.
“People are not getting their blood pressure checked at home and it can take days or weeks for them to get a check-up.
Even when they do get a blood test, the results are not always reliable,” says Dr Prakash Srivastava, a professor at Jawaharlal Nehru University and author of The Blood Brain Barrier: How to Cure it.
“We know that some people have a higher risk of developing dementia, especially if they have low cognitive function, and that the brain may be more vulnerable to Alzheimer’s disease, which is very difficult to treat.
So there are a lot more people who have a low risk of dementia than we have in the developed world.”
So, to tackle the problem, India is taking steps to get its population up to speed with blood-sugar tests and measures like using more effective medications to treat people with low blood sugar levels.
The most recent measures were announced by the government in September last year and are designed to help reduce the risk of blood brain damage.
They include a new national initiative to make blood tests and tests for blood sugar more effective, more accurate and more affordable.
Here are some of the challenges that India faces when it comes to getting people up to date with the latest medicines.
Is there an effective screening process for a blood sugar test?
India has not yet launched a national blood-test-based national strategy to improve access to the medicines, but there are signs that India is moving in the right direction.
India is one of the few countries in the world that does not have a national screening tool that allows people to see which medicines they need and which ones are available in their local market.
This is a key component of making sure that all medicines are safe and effective.
How do you determine which medicines are needed?
The country currently has a nationwide national blood test to determine if a patient is taking an essential drug, like insulin, or a more common type of medicine called blood glucose control.
However, this is only available in certain centres of the country.
“You can’t buy it in most hospitals in India, so the patient has to travel to a doctor or hospital in a neighbouring country to get it,” says Srivadav.
In other countries, the tests are provided in pharmacies or online.
This method is cheaper, but the cost is prohibitive.
So, when India launched the National Blood Sugar Monitoring Initiative in October 2016, it promised that the cost of the test would be lower than what it is in the rest of the world.
India also set up a national website for the national testing portal, www.bhsli.gov.in.
What is the impact of the lack of a national testing tool?
According to the government, the cost to a person of the national test is around Rs.4,000 and a patient has a 90 per cent chance of getting a positive result, but this depends on many factors.
The first factor is the blood sugar level.
A normal blood sugar is between 140 and 160 mg/dl, and for people with a low blood level, it may take a few hours for the blood glucose level to rise to normal.
For someone with a high blood level or diabetes, it could take up to a day to reach the normal range of blood glucose.
So people with high blood levels need to take medications such as anti-coagulants and anti-hypertensive drugs, and the more they take these, the longer the blood-pressure drop will be.
The second factor is how often the patient takes the medicines.
A person who takes two or three medicines a day will have a lower risk of getting diabetes.
The third factor is whether the medicines are prescribed for the same condition.
“The risk of a person with high levels of blood sugar taking a medication for diabetes increases exponentially when the blood pressure is low,” says Shrikant Dutt, a consultant cardiologist and the president of the National Diabetes Foundation of India (NDFI).
“If they have diabetes, they may not have the necessary amount of insulin or anti-diabetes medication, so they need to use anti-hyperglycemic drugs to manage their blood sugar.”
The fourth factor is what type of medication the patient is getting.
A regular patient will usually have lower blood sugar than a diabetic.
People with high cholesterol and diabetes may have a high level of insulin, and people with blood pressure issues may have low blood-glucose levels.
However when you take into account these other factors, a blood glucose test may be useful, but a blood pressure test is not as accurate or as accurate as a normal blood test. In